Accelerating the Biorevolution
September 15-17, 2025
Jesus College, University of Cambridge, UK
Vision
The Biorevolution is a term that explores how advances in the biotech, pharmaceutical, and biological industries and related technologies transform economies and societies globally. The Biorevolution rests on three key principles: accessibility, adaptability, and augmentation. Innovation is shaped through the prism of these three principles, strategically evaluating how technologies and approaches can become globally reachable and usable, adapt to ever-changing conditions and demographics, and increase impact. GapSummit 2025 will address the challenges and opportunities surrounding each of the three principles, inspiring innovative approaches to enable the Biorevolution.
Confirmed speakers
Dr Paul Burton
Chief Medical Officer, Amgen
Dr Stefan Lutz
SVP Research, Codexis
Dr Maria Soler Nunez
Head, Group Operations and Member of the Executive Committee, Lonza
Tony Hickson
Chief Business Officer, Cancer Research UK / Cancer Research Horizons
Dr Priya Singhal
EVP, Head of Development, Biogen
Dr Casper Vroemen
Chief D&D Officer, IFF
Prof Anne Ferguson-Smith
Executive Chair, UKRI-BBSRC
Dr Luca Quagliata
VP, Global Head of Medical Affairs, Thermo Fisher Scientific
Lubomila Jordanova
Co-Founder & CEO, PlanA
Dr Hermann Hauser
Co-Founder and Partner, Amadeus Capital Partners
Steve Rees
Senior Vice President, Discovery Biology, AstraZeneca
Dr Joanne Hackett
Vice President Health System Services, IQVIA
Dr Janice Chen
Co-Founder & CTO, Mammoth Biosciences
Prof Chris Bishop
Technical Fellow & Director, AI for Science, Microsoft Research
Aegis Prof Anike Te
Chief Strategy Officer and Aegis Professor of Engineering Biology, Lucideon and University of Bristol
Cristobal Foseca
CEO and Founder, Microendo
Benjamin Osborn
President, International Commercial Office, Pfizer
Bas Verhoef
Senior Vice President, Head of Region, Europe, Illumina
Dame Sally Davies
Master, Trinity College
Dr Jackie Hunter
CEO, OIPharmapartners Ltd
Birgit Marie Liodden
Founder & Chief Mermaid, The Ocean Opportunity Lab (TOOL)
Dr Alejandra Solache
SVP, Research & Development, Abcam
Dr Chris Meier
Managing Director and Partner, Boston Consulting Group
Dr Zuzanna Brzosko
Head of BD, Integrated Biosciences
Prof Ljiljana Fruk
Professor of BioNano Engineering, University of Cambridge
Dr Ajikumar Parayil
Founder and Chief Executive Officer, Manus
Juliana Lim
Executive Director, Community & Talent, SGInnovate
Prof Chwee Teck Lim
Director, Institute for Health Innovation and Technology, NUS
Dr Navraj Nagra
Associate Partner Host of McKinsey Life Sciences Innovation podcast, Eureka!, McKinsey & Company
Mr Tarquin Bennett-Coles
Director Life Sciences, Compass Carter Osborne
Dr Renuka Karandikar
CEO, BioPrime
Dr David Hughes
Head of Technology Identification and Evaluation, Syngenta
Marcus Stuttard
Head of UK Primary Markets & AIM, London Stock Exchange
Paula Rogers-Brown
Head of Communities & Ecosystem Engagement, University of Cambridge
Dr Ipshita Mandal-Johnson
Founding Partner, Global Bio Fund and Director, Mandal-Johnson Limited
Dr Gordon Sanghera
CEO, Oxford Nanopore Technologies plc
Dr Jason Mellad
CEO, OtoImmune
Dr Lucas Lieber
CEO, BioHeuris
Dr Tim Guilliams
CEO, Healx
Fiona Law
Partner - Patent Attorney, Potter Clarkson LLP
Dr Chris Booth
CEO, FYR Bio
Dr Nikolina Nakic
VP Target Discovery, NovoNordisk
GapSummit 2025 Team
Dr Adelina Ivanova
Executive Director
Dr Ioannis Prattis
Executive Director
John McGinty
Logistics Officer
Dr Ryan De Sotto
Marketing & Media Officer
Krupa Thakkar
Marketing & Media Officer
Dr Monika Witzenberger
Participant Officer
Nicky Wojtania
Participant Officer
Dr Victoria Auyeung
Participant Officer
GapSummit 2025 Sponsors
GapSummit 2025 Sponsors
